Literature DB >> 12594897

Coverage of enterococci in community acquired secondary peritonitis: results of a randomized trial.

A Röhrborn1, H Wacha, U Schöffel, A Billing, P Aeberhard, B Gebhard, I Böcker, V Schäfer, C Ohmann.   

Abstract

INTRODUCTION: The increasing number of enterococcal infections in hospitals and reports about the development of resistance of these bacteria make it necessary to review their importance as co-pathogens in secondary peritonitis.
MATERIALS AND METHODS: A prospective randomized controlled trial on primary therapy of secondary peritonitis was carried out in six centers comparing cephalosporin-based antibiotic therapy to acylaminopenicillin-based therapy.
RESULTS: Enterococci were only cultured in 6 of 110 cases from the abdomen and were found in only 5 cases of postoperative complications. No differences were found between penicillin-based vs. cephalosporin-based therapy.
CONCLUSION: The study supports the view that these bacteria continue to play a minor role in secondary peritonitis. The point has to be emphasized, however, that the patients under study were in relatively good condition (APACHE II median 9 for cephalosporins and 10 for penicillins) and that postoperative cases of peritonitis were excluded.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12594897     DOI: 10.1089/109629600321137

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  9 in total

1.  Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis.

Authors:  Emilia Cercenado; Luis Torroba; Rafael Cantón; Luis Martínez-Martínez; Fernando Chaves; Jose Angel García-Rodríguez; Carmen Lopez-Garcia; Lorenzo Aguilar; César García-Rey; Nuria García-Escribano; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

2.  Canadian practice guidelines for surgical intra-abdominal infections.

Authors:  Anthony W Chow; Gerald A Evans; Avery B Nathens; Chad G Ball; Glen Hansen; Godfrey Km Harding; Andrew W Kirkpatrick; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

3.  The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis.

Authors:  J de Ruiter; J Weel; E Manusama; W P Kingma; P H J van der Voort
Journal:  Infection       Date:  2009-12       Impact factor: 3.553

4.  Inflammation and the host response to injury, a large-scale collaborative project: patient-oriented research core--standard operating procedures for clinical care VII--Guidelines for antibiotic administration in severely injured patients.

Authors:  Michael A West; Ernest E Moore; Michael B Shapiro; Avery B Nathens; Joseph Cuschieri; Jeffrey L Johnson; Brian G Harbrecht; Joseph P Minei; Paul E Bankey; Ronald V Maier
Journal:  J Trauma       Date:  2008-12

Review 5.  Are there patients with peritonitis who require empiric therapy for enterococcus?

Authors:  S Harbarth; I Uckay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-21       Impact factor: 3.267

6.  Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis.

Authors:  J-H Lee; J-H Yoon; B H Kim; G E Chung; S J Myung; W Kim; Y J Kim; E-C Kim; H-S Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-09       Impact factor: 3.267

7.  Clinical Significance of Candida in an Intraoperative Peritoneal Specimen with Perforation Peritonitis: An Institutional Perspective.

Authors:  Jagannath Pramod; Chellappa Vijayakumar; Krishnamachari Srinivasan; Nanda Kishore Maroju; Nagarajan Raj Kumar; Gopal Balasubramaniyan
Journal:  Cureus       Date:  2018-03-05

8.  Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis.

Authors:  Florence C Riché; Xavier Dray; Marie-Josèphe Laisné; Joaquim Matéo; Laurent Raskine; Marie-José Sanson-Le Pors; Didier Payen; Patrice Valleur; Bernard P Cholley
Journal:  Crit Care       Date:  2009-06-24       Impact factor: 9.097

9.  Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care-an analysis of the OUTCOMEREA database.

Authors:  Anne-Cécile Morvan; Baptiste Hengy; Maïté Garrouste-Orgeas; Stéphane Ruckly; Jean-Marie Forel; Laurent Argaud; Thomas Rimmelé; Jean-Pierre Bedos; Elie Azoulay; Claire Dupuis; Bruno Mourvillier; Carole Schwebel; Jean-François Timsit
Journal:  Crit Care       Date:  2019-09-06       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.